Gregory I. Frost
2008
In 2008, Gregory I. Frost earned a total compensation of $487.8K as President and Chief Executive Officer at Halozyme Therapeutics, a 21% increase compared to previous year.
Compensation breakdown
| Option Awards | $164,455 |
|---|---|
| Salary | $323,000 |
| Other | $393 |
| Total | $487,848 |
Frost received $323K in salary, accounting for 66% of the total pay in 2008.
Frost also received $164.5K in option awards and $393 in other compensation.
Rankings
In 2008, Gregory I. Frost's compensation ranked 6,588th out of 9,135 executives tracked by ExecPay. In other words, Frost earned more than 27.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,588 out of 9,135 | 28th |
Division Manufacturing | 2,448 out of 3,436 | 29th |
Major group Chemicals And Allied Products | 546 out of 815 | 33rd |
Industry group Drugs | 376 out of 597 | 37th |
Industry Biological Products, Except Diagnostic Substances | 59 out of 118 | 50th |
Source: SEC filing on March 24, 2011.
Frost's colleagues
We found six more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2008.
2008
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2008
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
2008
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2008
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2008
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2008
David Ramsay
Halozyme Therapeutics